Predictive factors of response to IVIG in pediatric immune thrombocytopenic purpura.
Yukiko HigashideTsukasa HoriYuko YotoHiroyuki KabutoyaSaho HonjoYoshiyuki SakaiMasanori NojimaMinami YodaMasaki YamamotoHiroyuki TsutsumiPublished in: Pediatrics international : official journal of the Japan Pediatric Society (2018)
For new-onset ITP in patients aged >2 years, corticosteroid therapy in addition to IVIG may be considered as the initial treatment.